Pendal Group’s Chemours CC Stock Holding History

Pendal Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5,807	Closed	-$258K	–	453
2018 Q2	$258K	Buy	+5,807	New	+$289K	﹤0.01%	415

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pendal Group's CC Position: Q3 2018 in Review

Pendal Group sold out of Chemours (CC) in Q3 2018, closing a stake of 5,807 shares — an estimated $258K sold.

Pendal Group first reported a position in CC in Q2 2018 and held it in 1 quarter. The position peaked at $258K in Q2 2018. 551 funds tracked by Wall St. Rank hold CC as of Q3 2018.

Pendal Group reported no remaining Chemours position as of Q3 2018 after selling out during the quarter.
Pendal Group sold 5,807 Chemours shares in Q3 2018, an estimated $258K.
Pendal Group first reported a position in Chemours in Q2 2018 and held it in 1 quarter.
Pendal Group's Chemours position peaked at $258K in Q2 2018.
551 funds tracked by Wall St. Rank held Chemours as of Q3 2018.

Based on Pendal Group's 13F filing for Q3 2018, filed 5 Nov 2018.